PATENT CLAIM ANALYSIS

Application Number: 16017251
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "234100"]

Abstract:
The present invention relates to, in part, compositions comprising improved flagellin derived constructs and methods of using for vaccination, including adjuvants comprising flagellin-based agents.

Claim (Index 34):
The method of  claim 25 , wherein the flagellin-based agent comprises the amino acid sequence of SEQ ID NO: 2 and the antigen comprises succinyl methamphetamine (SMA) hapten conjugated to tetanus toxoid.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 94.0
- Lexical Diversity: 1.12
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15500133', '12532225', '13898249', '15329870', '15446315']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7056585194493745
- 35 USC 102 Novelty (BERT): 0.6213132830342634
- Combined Prediction Score: 0.6972239958078634
- Mean Citation Score: 350.1240180000001
- Max Citation Score: 672.6575
- Similarity Product: 467.467889893055

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test